Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

491 public trials 153 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Not Yet Recruiting

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NCT06175845

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +20 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Not Yet Recruiting

The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases

NCT05896956

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +22 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma

NCT05644743

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant PDT in the Treatment of Cholangiocarcinoma

NCT04824742

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Yi Lv Xi'an, Shaanxi, China

View Trial Details

Completed

Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation

NCT07704021

Conditions: Adenocarcinoma, Biliary Tract Diseases, Carcinoma, +15 more
Locations: Ospedale Guglielmo da Saliceto di Piacenza Piacenza, PC, Italy

View Trial Details

Completed

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

NCT01862315

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations: Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

Memorial Sloan Kettering Westchester Harrison, New York, United States

View Trial Details

Completed

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

NCT05185947

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +43 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Optimization of Health Expenditure in Liver Surgery

NCT01715402

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
Locations: Amiens North Hospital Amiens, France

Bordeaux Hospital Bordeaux, France

Beaujon University Hospital Clichy, France

Lille Regional Hospital Lille, France

View Trial Details

Completed

Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma

NCT07619937

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Completed

Prospective Evaluation of Biliary Tissue Sampling With ERCP

NCT04572711

Conditions: Adenocarcinoma, Biliary Stricture, Biliary Tract Diseases, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details